RLAY – relay therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Relay Therapeutics (RLAY) had its price target raised by HC Wainwright from $14.00 to $19.00. They now have a "buy" rating on the stock.
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. [Yahoo! Finance]
Relay Therapeutics (RLAY) had its price target raised by Citizens Jmp from $15.00 to $17.00. They now have a "market outperform" rating on the stock.
Relay Therapeutics (RLAY) had its price target raised by Wells Fargo & Company from $15.00 to $17.00. They now have an "overweight" rating on the stock.
Relay Therapeutics (RLAY) had its "outperform" rating reaffirmed by Oppenheimer Holdings, Inc..
Form SCHEDULE 13G/A Relay Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Form SCHEDULE 13G Relay Therapeutics, Inc. Filed by: PERCEPTIVE ADVISORS LLC
Form 8-K Relay Therapeutics, Inc. For: Mar 16
Form 4 Relay Therapeutics, Inc. For: Mar 09 Filed by: Catinazzo Thomas
Form 8-K Relay Therapeutics, Inc. For: Mar 06
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.